Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May;70(5):1539-1545.
doi: 10.4103/ijo.IJO_2245_21.

Noninvasive ocular surface analyzer as an adjunct in diagnosis and estimating prevalence of meibomian gland dysfunction: Hospital-based comparative study

Saumya Yadav  1 , Noopur Gupta  1 , Tarjani Makwana  1 , Murugesan Vanathi  1 , Radhika Tandon  1
Affiliations

Noninvasive ocular surface analyzer as an adjunct in diagnosis and estimating prevalence of meibomian gland dysfunction: Hospital-based comparative study

Saumya Yadav et al. Indian J Ophthalmol. 2022 May.

Abstract

Purpose: To assess the role of noninvasive ocular surface analyzer (OSA) in workup of meibomian gland dysfunction (MGD) and to estimate hospital-based prevalence of MGD using this objective device.

Methods: The study recruited 113 consecutive participants attending the ophthalmology outpatient department of a tertiary care hospital. All participants were administered a symptom questionnaire. Participants underwent a comprehensive ocular examination, including slit-lamp biomicroscopy and meibomian gland expression. Lipid layer thickness (LLT), noninvasive tear breakup time (NIBUT), tear meniscus height (TMH), and meibomian gland loss (MGL) were assessed using OSA. The presence of either or both reduced/absent meibum secretion and cloudy to toothpaste-like secretion was diagnosed as MGD.

Results: Prevalence of total MGD was 57.52% (95% confidence interval [95% CI]: 48.3%-66.8%) and that of symptomatic MGD was 42.5% (95% CI: 33.2%-51.7%). Prevalence of total and symptomatic MGD was highest in those aged ≥50 years (P < 0.001 and P = 0.004, respectively). Computer vision syndrome increased the odds of symptomatic MGD (odds ratio [OR]: 4.3). NIBUT and MGL significantly differed in MGD and non-MGD groups (P = 0.023 and P < 0.001, respectively). LLT significantly differed between asymptomatic and symptomatic cases (P = 0.033). MGL >25% increased the odds of having MGD (OR: 19.1). Significant negative correlations were observed between MGL and NIBUT (P = 0.04) and between MGL and LLT (P = 0.02). MGL demonstrated the highest diagnostic accuracy for MGD (AUC = 0.827, sensitivity = 75.4%, specificity = 85.4%, cut-off value: ≥26%).

Conclusion: MGD is a common disorder in adults attending the ophthalmology outpatient services of a tertiary eye care hospital. Incorporating noninvasive OSA in clinical practice can aid in rapid and reliable measurements of MGD-related parameters.

Keywords: Dry Eye; meibomian gland dysfunction; meibomian gland loss; meibomian glands; ocular surface analyzer.

PubMed Disclaimer

Conflict of interest statement

None

Figures

Figure 1
Figure 1
Examination of the ocular surface through slit-lamp–mounted ocular surface analyzer, an integrated platform for diagnosis of dry eye disease
Figure 2
Figure 2
ROC curves for NIBUT, MGL, LLT, and TMH. LLT = lipid layer thickness, MGL = meibomian gland loss, NIBUT = noninvasive tear breakup time, ROC = receiver operating characteristic, TMH = tear meniscus height
See this image and copyright information in PMC

Comment in

References

    1. Tong L, Chaurasia SS, Mehta JS, Beuerman RW. Screening for meibomian gland disease: Its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci. 2010;51:3449–54. - PubMed
    1. Kim J, Hwang Y, Kang S, Kim M, Kim TS, Kim J, et al. Association between exposure to smartphones and ocular health in adolescents. Ophthalmic Epidemiol. 2016;23:269–76. - PubMed
    1. Schein OD, Tielsch JM, Munõz B, Bandeen-Roche K, West S. Relation between signs and symptoms of dry eye in the elderly A population-based perspective. Ophthalmology. 1997;104:1395–401. - PubMed
    1. Viso E, Rodríguez-Ares MT, Abelenda D, Oubiña B, Gude F. Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. Invest Ophthalmol Vis Sci. 2012;53:2601–6. - PubMed
    1. Siak JJK, Tong L, Wong WL, Cajucom-Uy H, Rosman M, Saw SM, et al. Prevalence and risk factors of meibomian gland dysfunction: The Singapore Malay eye study. Cornea. 2012;31:1223–8. - PubMed